BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27830477)

  • 1. Association of thyroid hormone concentrations with quality of life of primary brain tumor patients: a pilot study.
    Bunevicius A; Laws ER; Deltuva V; Tamasauskas A
    J Neurooncol; 2017 Jan; 131(2):385-391. PubMed ID: 27830477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of health-related quality of life in Lithuanian brain tumor patients using the EORTC brain cancer module.
    Bunevičius A; Tamašauskas Š; Tamašauskas A; Deltuva V
    Medicina (Kaunas); 2012; 48(11):588-94. PubMed ID: 23455894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No Effect of the Thr92Ala Polymorphism of Deiodinase-2 on Thyroid Hormone Parameters, Health-Related Quality of Life, and Cognitive Functioning in a Large Population-Based Cohort Study.
    Wouters HJ; van Loon HC; van der Klauw MM; Elderson MF; Slagter SN; Kobold AM; Kema IP; Links TP; van Vliet-Ostaptchouk JV; Wolffenbuttel BH
    Thyroid; 2017 Feb; 27(2):147-155. PubMed ID: 27786042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating patients for psychosocial distress and supportive care needs based on health-related quality of life in primary brain tumors: a prospective multicenter analysis of patients with gliomas in an outpatient setting.
    Hickmann AK; Hechtner M; Nadji-Ohl M; Janko M; Reuter AK; Kohlmann K; Haug M; Grüninger S; Deininger M; Ganslandt O; König J; Wirtz CR; Coburger J; Renovanz M
    J Neurooncol; 2017 Jan; 131(1):135-151. PubMed ID: 27638638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
    Caissie A; Nguyen J; Chen E; Zhang L; Sahgal A; Clemons M; Kerba M; Arnalot PF; Danjoux C; Tsao M; Barnes E; Holden L; Danielson B; Chow E
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1238-45. PubMed ID: 22172909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30.
    Chiu L; Chiu N; Zeng L; Zhang L; Popovic M; Chow R; Lam H; Poon M; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2012 Dec; 12(6):831-7. PubMed ID: 23252363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative low tri-iodothyronine concentration is associated with worse health status and shorter five year survival of primary brain tumor patients.
    Bunevicius A; Deltuva VP; Tamasauskas S; Smith T; Laws ER; Bunevicius R; Iervasi G; Tamasauskas A
    Oncotarget; 2017 Jan; 8(5):8648-8656. PubMed ID: 28055959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.
    Taphoorn MJ; Claassens L; Aaronson NK; Coens C; Mauer M; Osoba D; Stupp R; Mirimanoff RO; van den Bent MJ; Bottomley A;
    Eur J Cancer; 2010 Apr; 46(6):1033-40. PubMed ID: 20181476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of perinatal asphyxia on thyroid-stimulating hormone and thyroid hormone levels.
    Pereira DN; Procianoy RS
    Acta Paediatr; 2003; 92(3):339-45. PubMed ID: 12725550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life and distress in elderly vs. younger patients with high-grade glioma-results of a multicenter study.
    Renovanz M; Hickmann AK; Nadji-Ohl M; Keric N; Weimann E; Wirtz CR; Singer S; Ringel F; Coburger J
    Support Care Cancer; 2020 Nov; 28(11):5165-5175. PubMed ID: 32060706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health related quality of life (HRQOL) in long-term survivors of pediatric low grade gliomas (LGGs).
    Nwachukwu CR; Youland RS; Chioreso C; Wetjen N; NageswaraRao A; Keating G; Laack NN
    J Neurooncol; 2015 Feb; 121(3):599-607. PubMed ID: 25467557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients.
    Maringwa J; Quinten C; King M; Ringash J; Osoba D; Coens C; Martinelli F; Reeve BB; Gotay C; Greimel E; Flechtner H; Cleeland CS; Schmucker-Von Koch J; Weis J; Van Den Bent MJ; Stupp R; Taphoorn MJ; Bottomley A;
    Ann Oncol; 2011 Sep; 22(9):2107-2112. PubMed ID: 21324954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients.
    Li L; Chan SL; Mo F; Hui EP; Koh J; Chan AK; Tang NL; Chu CM; Hui J; Lee KF; Yu S; Yeo W
    Qual Life Res; 2019 Sep; 28(9):2597-2607. PubMed ID: 31037590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
    Li Q; Lin Y; Qiu Y; Gao B; Xu Y
    Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.
    Heutte N; Flechtner HH; Mounier N; Mellink WA; Meerwaldt JH; Eghbali H; van't Veer MB; Noordijk EM; Kluin-Nelemans JC; Lampka E; Thomas J; Lugtenburg PJ; Viterbo L; Carde P; Hagenbeek A; van der Maazen RW; Smit WG; Brice P; van Marwijk Kooy M; Baars JW; Poortmans P; Tirelli U; Leeksma OC; Tomsic R; Feugier P; Salles G; Gabarre J; Kersten MJ; Van Den Neste E; Creemers GJ; Gaillard I; Meijnders P; Tertian G; Reman O; Muller HP; Troncy J; Blanc M; Schroyens W; Voogt PJ; Wijermans P; Rieux C; Fermé C; Henry-Amar M;
    Lancet Oncol; 2009 Dec; 10(12):1160-70. PubMed ID: 19828373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in glioma patients in China.
    Cheng JX; Liu BL; Zhang X; Lin W; Zhang YQ; Liu WP; Zhang JN; Lin H; Wang R; Yin H
    BMC Cancer; 2010 Jun; 10():305. PubMed ID: 20565883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive functioning and health-related quality of life in patients treated with stereotactic radiotherapy for brain metastases: a prospective study.
    Habets EJ; Dirven L; Wiggenraad RG; Verbeek-de Kanter A; Lycklama À Nijeholt GJ; Zwinkels H; Klein M; Taphoorn MJ
    Neuro Oncol; 2016 Mar; 18(3):435-44. PubMed ID: 26385615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme.
    Gamper EM; Wintner LM; Rodrigues M; Buxbaum S; Nilica B; Singer S; Giesinger JM; Holzner B; Virgolini I
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1179-88. PubMed ID: 25771905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free thyroxine, free triiodothyronine and thyroid-stimulating hormone before and after hemodialysis in Saudi patients with end-stage renal disease: is there any difference?
    Alsaran K; Sabry A; Alshahhat H; Babgy E; Alzahrani F
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):917-21. PubMed ID: 21912019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.